O'Rourke M
School of Medicine, University of New South Wales, St. Vincent's Hospital, Darlinghurst, Australia.
J Hum Hypertens. 1989 Jun;3 Suppl 1:47-52.
Arterial stiffness (the inverse of compliance) is the major determinant of left ventricular and central aortic peak systolic pressure. Recent prospective epidemiological studies (MRFIT, Framingham) have confirmed the importance of systolic (rather than diastolic) pressure in the development of cardiac failure and stroke, and in all-cause mortality. Arteries stiffen in hypertension and with increasing age. Arterial stiffening increases systolic pressure by two mechanisms. The first is by causing a higher pressure to be generated at the peak of ventricular ejection (through increase in aortic characteristic impedance), and the second is by causing a secondary rise attributable to early return of wave reflection from peripheral sites (through an increase in arterial pulse wave velocity). ACE inhibitors, and also nitrates, decrease arterial stiffness. They also dilate peripheral conduit arteries; this reduces wave reflection. These drugs thus reduce systolic pressure in central arteries not only by reducing arterial stiffness but also by reducing inappropriately early wave reflection. Quantitatively, the latter action seems to be more important than the former. Neither action is seen with beta-blocking agents. These beneficial actions on central systolic pressure are not always apparent when pressure is measured in a peripheral artery such as the brachial or radial. This is because the reflected wave constitutes the peak of the pressure wave in central arteries but is usually just an undulation on the downstroke of the wave in peripheral arteries. Hence sphygmomanometric recordings underestimate reduction in central systolic pressure and in left ventricular load brought about by ACE inhibitors and by nitrates.
动脉僵硬度(顺应性的倒数)是左心室和中心主动脉收缩压峰值的主要决定因素。最近的前瞻性流行病学研究(多重危险因素干预试验、弗雷明汉研究)证实了收缩压(而非舒张压)在心力衰竭、中风发展以及全因死亡率中的重要性。动脉在高血压状态下以及随着年龄增长会变硬。动脉变硬通过两种机制升高收缩压。第一种机制是在心室射血峰值时产生更高的压力(通过增加主动脉特性阻抗),第二种机制是由于外周部位的波反射提前返回导致继发性升高(通过增加动脉脉搏波速度)。血管紧张素转换酶抑制剂以及硝酸盐类药物可降低动脉僵硬度。它们还能扩张外周传导动脉;这减少了波反射。因此,这些药物降低中心动脉收缩压不仅是通过降低动脉僵硬度,还通过减少不适当的早期波反射。从数量上看,后一种作用似乎比前一种更重要。β受体阻滞剂则没有这两种作用。当在诸如肱动脉或桡动脉等外周动脉测量血压时,这些对中心收缩压的有益作用并不总是明显。这是因为反射波在中心动脉中构成压力波的峰值,但在外周动脉中通常只是波下降过程中的一个波动。因此,血压计记录低估了血管紧张素转换酶抑制剂和硝酸盐类药物引起的中心收缩压降低以及左心室负荷的降低。